Insurance companies are starting to send warning letters to doctors and health care providers suspected of a practice known as off-label prescribing for the drug Ozempic.
, include threats such as the possibility of reporting “suspected inappropriate or fraudulent activity … to the state licensure board, federal and/or state law enforcement.”
It’s the latest chapter in the story of the popular, highly effective, and very expensive drug intended for diabetes that results in quick weight loss. Off-label prescribing means a medicine has been prescribed for a reason other than the uses approved by the FDA. The practice is common and legal . But insurance companies are pushing back because many do not cover weight loss medications, while they do cover diabetes treatments. The insurance company letters suggest that prescribers are failing to document in a person’s medical record that the person actually has diabetes.
Ozempic, which is FDA approved for treatment of diabetes, is similar to the drug Wegovy, which is approved to be used for weight loss. Ozempic typically costs more than $900 per month. Both Wegovy and Ozempic contain semaglutide, which mimics a hormone that helps the brain regulate appetite and food intake. Clinical studies show that after taking semaglutide for more than 5 years, people lose on average 17% of their body weight.
Demand for both Ozempic and Wegovy has been surging, leading to shortages and tactics to acquire the drugs outside of the U.S., as well as warnings from public health officials about the dangers of knockoff versions of the drugs. The“Obesity is a complex disease involving an excessive amount of body fat,” the Mayo Clinic explains. “Obesity isn't just a cosmetic concern.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Insurers clamping down on doctors who prescribe Ozempic for weight lossWeight-loss drugs known as GLP-1s have created a frenzy among patients and investors, but the true size of the market may come down to how insurers cover the drugs.
Read more »
Amy Schumer slams other stars for 'lying' about being on Ozempic | CNNAmy Schumer is not holding back when it comes to celebrities and diet trends.
Read more »
Amy Schumer details Ozempic side effects, says she felt too sick to play with sonThe comedian said she was briefly prescribed the drug, which helps people lose weight, and criticized other celebrities for not admitting to taking it.
Read more »
TikTok users calling berberine 'nature's Ozempic' but is it?TikTok users have been testing out berberine, which is an herbal supplement, that is gaining popularity for its alleged weight loss effects.
Read more »
Lawmakers passed a bill to stop insurers from considering ESG criteria in setting ratesSo-called environmental, social and governance policies are often adopted by companies to reduce their carbon footprints. The new Texas bill aims to stop insurers doing business in Texas from using ESG criteria, but it doesn’t include penalties for violations.
Read more »